Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof

A method of producing an immune response against porcine circovirus type 3 (PCV3) in a pregnant sow or pregnant gilt, wherein said method comprises administering a composition comprising a recombinant PCV3 ORF2 protein to the pregnant sow or pregnant gilt, wherein the composition further comprises a veterinary-acceptable carrier selected from the group consisting of a solvent, a dispersion media, a coating, a stabilizing agent, a diluent, a preservative, an anti-microbial agent, an antifungal agent, an isotonic agent, an adsorption delaying agent, an adjuvant, cell culture supernatant, a stabilizing agent, a viral vector, an expression vector, and an immunomodulatory agent, or any combination thereof.